Celldex Therapeutics (CLDX)
(Delayed Data from NSDQ)
$40.96 USD
+0.79 (1.97%)
Updated Sep 24, 2024 03:59 PM ET
After-Market: $41.00 +0.04 (0.10%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -0.69 |
EPS Last Quarter | -0.54 |
Last EPS Surprise | 8.47% |
ABR | 1.20 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.50 |
Next Year | -3.03 |
EPS (TTM) | -2.48 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.44M | 1.41M | 4.45M | 7.37M |
# of Estimates | 3 | 3 | 4 | 3 |
High Estimate | 2.32M | 2.23M | 7.20M | 12.00M |
Low Estimate | 1.00M | 1.00M | 2.70M | 4.70M |
Year ago Sales | 1.52M | 4.13M | 6.88M | 4.45M |
Year over Year Growth Est. | -5.26% | -65.86% | -35.36% | 65.53% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.69 | -0.73 | -2.50 | -3.03 |
# of Estimates | 6 | 5 | 7 | 5 |
Most Recent Consensus | -0.70 | -0.71 | -2.62 | -3.05 |
High Estimate | -0.61 | -0.66 | -2.26 | -2.77 |
Low Estimate | -0.75 | -0.84 | -2.83 | -3.37 |
Year ago EPS | -0.81 | -0.57 | -2.66 | -2.50 |
Year over Year Growth Est. | 14.81% | -28.07% | 6.02% | -21.30% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 4 | 4 | 5 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.69 | -0.73 | -2.50 | -3.03 |
7 Days Ago | -0.69 | -0.73 | -2.50 | -3.03 |
30 Days Ago | -0.69 | -0.73 | -2.50 | -3.03 |
60 Days Ago | -0.61 | -0.64 | -2.39 | -2.85 |
90 Days Ago | -0.61 | -0.64 | -2.39 | -2.85 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.69 | -0.73 | -2.50 | -3.03 |
Zacks Consensus Estimate | -0.69 | -0.73 | -2.50 | -3.03 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.54 | -0.56 | -0.57 | -0.81 | NA |
Estimate | -0.59 | -0.67 | -0.76 | -0.67 | NA |
Difference | 0.05 | 0.11 | 0.19 | -0.14 | 0.05 |
Surprise | 8.47% | 16.42% | 25.00% | -20.90% | 7.25% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more